Rafferty Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,545
| Closed | -$250K | – | 1090 |
|
|
2025
Q1 | $250K | Sell |
7,545
-560
| -7% | -$18.6K | ﹤0.01% | 999 |
|
|
2024
Q4 | $279K | Buy |
+8,105
| New | +$279K | ﹤0.01% | 1039 |
|
|
2024
Q1 | – | Sell |
-7,374
| Closed | -$238K | – | 1087 |
|
|
2023
Q4 | $238K | Buy |
+7,374
| New | +$238K | ﹤0.01% | 1046 |
|
|
2022
Q4 | – | Sell |
-5,223
| Closed | -$231K | – | 1133 |
|
|
2022
Q3 | $231K | Buy |
5,223
+26
| +0.5% | +$1.15K | ﹤0.01% | 1066 |
|
|
2022
Q2 | $253K | Buy |
+5,197
| New | +$253K | ﹤0.01% | 978 |
|
|
2022
Q1 | – | Sell |
-6,585
| Closed | -$281K | – | 1266 |
|
|
2021
Q4 | $281K | Buy |
+6,585
| New | +$281K | ﹤0.01% | 1160 |
|